1,256
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Design and testing of a health economic Markov model for treatment of anorexia nervosa

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1243-1251 | Received 27 Dec 2021, Accepted 26 Aug 2022, Published online: 01 Sep 2022

References

  • Treasure J, Zipfel S, Micali N, et al. Anorexia nervosa. Nat Rev Dis Primers. 2015 Nov 26;1(1):15074.
  • Zipfel S, Giel KE, Bulik CM, et al. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry. 2015 Dec;2(12):1099–1111.
  • van Eeden AE, van Hoeken D, Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry. 2021 Nov 1;34(6):515–524.
  • Stoving RK, Andries A, Brixen K, et al. Gender differences in outcome of eating disorders: a retrospective cohort study. Psychiatry Res. 2011 Apr 30;186(2–3):362–366.
  • Striegel Weissman R, Rosselli F. Reducing the burden of suffering from eating disorders: unmet treatment needs, cost of illness, and the quest for cost-effectiveness. Behav Res Ther. 2017 01;88:49–64.
  • Le LK, Mihalopoulos C, Engel L, et al. Burden and health state utility values of eating disorders: results from a population-based survey. Psychol Med. 2021 01; 51(1):130–137.
  • Stuhldreher N, Wild B, König HH, et al. Determinants of direct and indirect costs in anorexia nervosa. Int J Eat Disord. 2015 Jan;48(1):139–146.
  • Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 2016 11;29(6):340–345.
  • Bode K, Götz von Olenhusen NM, Wunsch EM, et al. Population-based cost-offset analyses for disorder-specific treatment of anorexia nervosa and bulimia nervosa in Germany. Int J Eat Disord. 2017 Mar;50(3):239–249.
  • Stuhldreher N, Konnopka A, Wild B, et al. Cost-of-illness studies and cost-effectiveness analyses in eating disorders: a systematic review. Int J Eat Disord. 2012 May;45(4):476–491.
  • Brockmeyer T, Friederich HC, Schmidt U. Advances in the treatment of anorexia nervosa: a review of established and emerging interventions. Psychol Med. 2018 06;48(8):1228–1256.
  • Couturier J, Kimber M, Szatmari P. Efficacy of family-based treatment for adolescents with eating disorders: a systematic review and meta-analysis. Int J Eat Disord. 2013 Jan;46(1):3–11.
  • Halvorsen I, Ø R. User satisfaction with family-based inpatient treatment for adolescent anorexia nervosa: retrospective views of patients and parents. J Eat Disord. 2019;7(1):12.
  • Fisher CA, Skocic S, Rutherford KA, et al. Family therapy approaches for anorexia nervosa. Cochrane Database Syst Rev. 2019 05;5: CD004780 DOI:10.1002/14651858.CD004780.pub4.
  • Crow SJ, Nyman JA. The cost-effectiveness of anorexia nervosa treatment. Int J Eat Disord. 2004 Mar;35(2):155–160.
  • Le LK, Barendregt JJ, Hay P, et al. The modeled cost-effectiveness of family-based and adolescent-focused treatment for anorexia nervosa. Int J Eat Disord. 2017 12; 50(12):1356–1366.
  • Wright DR, Austin SB, LeAnn Noh H, et al. The cost-effectiveness of school-based eating disorder screening. Am J Public Health. 2014 Sep;104(9):1774–1782.
  • Le LK, Barendregt JJ, Hay P, et al. The modelled cost-effectiveness of cognitive dissonance for the prevention of anorexia nervosa and bulimia nervosa in adolescent girls in Australia. Int J Eat Disord. 2017 07; 50(7):834–841.
  • Lokkerbol J, Wijnen B, Ruhe HG, et al. Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder. Expert Rev Pharmacoecon Outcomes Res. 2020 Nov;21(5):1031–42. • Similar applications of health economic models within psychiatry.
  • Wijnen BFM, Thielen FW, Konings S, et al. Designing and testing of a health-economic Markov model for prevention and treatment of early psychosis. Expert Rev Pharmacoecon Outcomes Res. 2020 Jun;20(3):269–279.
  • Le LK, Hay P, Mihalopoulos C. A systematic review of cost-effectiveness studies of prevention and treatment for eating disorders. Aust N Z J Psychiatry. 2018 04;52(4):328–338.
  • Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ. 2013 Mar;346:f1049.
  • Nederland Z. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg [Guideline for conducting economic assessments in health care]. Diemen: Zorginstituut Nederland; 2015. Dutch.
  • Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Mak. 1993 Dec 01;13(4):322–338.
  • Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. New York: Oxford University Press; 2006.
  • Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998 Apr;13(4):397–409.
  • Caro JJ, Briggs AH, Siebert U, et al. Modeling good research practices–overview: a report of the ISPOR-SMDM modeling good research practices task force–1. Value Health. 2012 Sep-Oct;15(6):796–803.
  • Steinglass JE, Glasofer DR, Dalack M, et al. Between wellness, relapse, and remission: stages of illness in anorexia nervosa. Int J Eat Disord. 2020 07;53(7):1088–1096.
  • de Zwart PL, Jeronimus BF, de Jonge P. Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review. Epidemiol Psychiatr Sci. 2019 Oct;28(5):544–562.
  • Bardone-Cone AM, Hunt RA, Watson HJ. An overview of conceptualizations of eating disorder recovery, recent findings, and future directions. Curr Psychiatry Rep. 2018 08;20(9):79.
  • Wade TD, Lock J. Developing consensus on the definition of remission and recovery for research. Int J Eat Disord. 2020 08;53(8):1204–1208.
  • Bardone-Cone AM, Alvarez A, Gorlick J, et al. Longitudinal follow-up of a comprehensive operationalization of eating disorder recovery: concurrent and predictive validity. Int J Eat Disord. 2019 09; 52(9):1052–1057.
  • Fichter MM, Quadflieg N, Crosby RD, et al. Long-term outcome of anorexia nervosa: results from a large clinical longitudinal study. Int J Eat Disord. 2017 09; 50(9):1018–1030.
  • Tomba E, Tecuta L, Crocetti E, et al. Residual eating disorder symptoms and clinical features in remitted and recovered eating disorder patients: a systematic review with meta-analysis. Int J Eat Disord. 2019 07; 52(7):759–776.
  • Volpe U, Tortorella A, Manchia M, et al. Eating disorders: what age at onset? Psychiatry Res. 2016 Apr;238:225–227.
  • Drummond M,F, Sculpher MJ, Claxton K. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 2015.
  • Khalsa SS, Portnoff LC, McCurdy-McKinnon D, et al. What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J Eat Disord. 2017;5(1):20.
  • Berends T, Boonstra N, van Elburg A. Relapse in anorexia nervosa: a systematic review and meta-analysis. Curr Opin Psychiatry. 2018 11;31(6):445–455.
  • Kordy H, Krämer B, Palmer RL, et al. Remission, recovery, relapse, and recurrence in eating disorders: conceptualization and illustration of a validation strategy. J Clin Psychol. 2002 Jul;58(7):833–846.
  • Statline. Sterfte; geslacht, leeftijd (op 31 December) en burgerlijke staat 1950-2014. [Mortality; gender, age (on December 31) and marital status 1950-2014] 2015. Available from: https://opendata.cbs.nl/statline/#/CBS/nl/dataset/37530NED/table?fromstatwebDutch
  • Arcelus J, Mitchell AJ, Wales J, et al. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011 Jul;68(7):724–731.
  • Berends T, van Meijel B, Nugteren W, et al. Rate, timing and predictors of relapse in patients with anorexia nervosa following a relapse prevention program: a cohort study. BMC Psychiatry. 2016 09; 16(1):316.
  • Herzog DB, Dorer DJ, Keel PK, et al. Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow-up study. J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):829–837.
  • Strober M, Freeman R, Morrell W. The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study. Int J Eat Disord. 1997 Dec;22(4):339–360.
  • Hakkaart-van Roijen L, Van der Linden N, Bouwmans C, et al. Kostenhandleiding. Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg In opdracht van Zorginstituut Nederland Geactualiseerde versie [Cost guide, methodology of cost research and reference prices for economic evaluations in health care, commissioned by the national health care institute, updated version]. 2015. Dutch
  • Egger N, Wild B, Zipfel S, et al. Cost-effectiveness of focal psychodynamic therapy and enhanced cognitive-behavioural therapy in outpatients with anorexia nervosa. Psychol Med. 2016 12; 46(16):3291–3301.
  • CBS. Consumer prices; price index 2022. Available from: https://www.cbs.nl/en-gb/figures/detail/83131eng
  • Vemer P, Corro Ramos I, van Voorn GA, et al. AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics. 2016 Apr;34(4):349–361.
  • RVZ. Zinnige en duurzame zorg 2006 [Sensible and sustainable care 2006]. Available from: https://www.raadrvs.nl/binaries/raadrvs/documenten/publicaties/2006/06/07/zinnige-en-duurzame-zorg/Advies_-_Zinnige_en_duurzame_zorg.pdfDutch
  • Watson I, Bouvy J, Dent R, et al. CHTE methods review: discounting 2020. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/nice-guidance/chte-methods-consultation/Discounting-task-and-finish-group-report.docx
  • Ernst V, Bürger A, Hammerle F. Prevalence and severity of eating disorders: a comparison of DSM-IV and DSM-5 among German adolescents. Int J Eat Disord. 2017 11;50(11):1255–1263.
  • Fairburn CG, Cooper Z. Eating disorders, DSM–5 and clinical reality. Br J Psychiatry. 2011;198(1):8–10.